Symposium on Clinical Interventional Oncology (CIO 2018)

 

Symposium on Clinical Interventional Oncology (CIO 2018)
Avatar

Declaring Mistrials: What to Make of the Negative IO Studies and Other Literature Conundrums - SARAH/SIRVENIB Trials

By Symposium on Clinical Interventional Oncology (CIO 2018) FEATURING William Rilling
By Symposium on Clinical Interventional Oncology (CIO 2018) FEATURING William Rilling
659 views
January 4, 2019
0 Comments
Login to view comments. Click here to Login
Session 2
10:24

The Big Picture: The Value of IO in a Major Cancer Center

Symposium on Clinical Interventional Oncology (CIO 2018)

245 views
08:24

Review of the SIRFLOX-FOXFIRE Trials

Symposium on Clinical Interventional Oncology (CIO 2018)

S. Padia

255 views
05:06

Declaring Mistrials: What to Make of the Negative IO Studies and Oth…

Symposium on Clinical Interventional Oncology (CIO 2018)

R. Salem

228 views
09:13

Transarterial Trials with Potential Confounders

Symposium on Clinical Interventional Oncology (CIO 2018)

K. Brown

430 views
05:21

Declaring Mistrials: What to Make of the Negative IO Studies and Oth…

Symposium on Clinical Interventional Oncology (CIO 2018)

24 views
04:49

Interpreting Trials: Local Treatment of Unresectable Colorectal Live…

Symposium on Clinical Interventional Oncology (CIO 2018)

D. Sze

82 views
31:36

Buzzkill Corner: The Existential Threats to Interventional Oncology …

Symposium on Clinical Interventional Oncology (CIO 2018)

C. Ray

514 views
05:21

Declaring Mistrials: What to Make of the Negative IO Studies and Oth…

Symposium on Clinical Interventional Oncology (CIO 2018)

W. Rilling

659 views